Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer

Kristoffer B. Kristensen*, Ida Marie Nedergaard Thomsen, Tobias Berg, Annette R. Kodahl, Anders Bonde Jensen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences